----item----
version: 1
id: {DC2A5CCC-A600-4B6C-9931-2A229F85CD21}
database: master
path: /sitecore/content/ScripIntelligence/Home/Articles/2015/07/14/PharmAsia News business bulletin
parent: {CDA12E48-3499-4F0B-8DA5-8FF067DDAF1D}
name: PharmAsia News business bulletin
master: {00000000-0000-0000-0000-000000000000}
template: {11380B5D-3531-4570-B213-EFC5312266E4}
templatekey: Article

----version----
language: en
version: 1
revision: 2774507c-0963-4463-ba09-701a93052fa7

----field----
field: {2D750EFF-9058-4ABF-A7FF-57FFE5DA1E3C}
name: Title
key: title
content-length: 32

PharmAsia News business bulletin
----field----
field: {F1D1DC93-63DF-4AFA-B60F-B3A3E9D36675}
name: Sub Title
key: sub title
content-length: 32

PharmAsia News business bulletin
----field----
field: {446A339B-E1D9-4DE1-8B5E-DB7942EF1723}
name: Body
key: body
content-length: 4385

<p>A new regular roundup of commercial stories appearing in <i>Scrip</i>'s sister publication <i>PharmAsia News</i>, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. </p><p>Full stories can be accessed by clicking on the story title (subscription required). </p><p><p><a href="https://www.pharmamedtechbi.com/publications/pharmasia-news/2015/7/9/china-looks-at-innovation-quality-policies-as-chronic-diseases-rise" target="_new">China Looks At Innovation, Quality Policies As Chronic Diseases Rise</a></p><p>Maximizing innovation and focusing on product quality should be prioritized in China's next Five-Year Plan for the pharma industry, representatives proposed at a recent government meeting. Meanwhile, data from the national health regulator have indicated a sharp rise in chronic diseases and obesity in the country.</p><p><p><a href="https://www.pharmamedtechbi.com/publications/pharmasia-news/2015/7/14/turkey-drug-prices-to-rise-4-as-govt-settles-euro-issue" target="_new">Turkey Drug Prices To Rise 4% As Govt Settles Euro Issue</a></p><p>The government of Turkey has finally settled the drug euro exchange rate debate with a decree setting a new figure for the rest of 2015, which will mean a 4% increase in prices. The decree has also described a clear method to determine the fixed euro rate to be used in price calculations every year, but the industry is still not completely satisfied.</p><p><p><a href="https://www.pharmamedtechbi.com/publications/pharmasia-news/2015/7/15/ineffective-indian-price-controls-need-rethink-study" target="_new">'Ineffective' Indian Price Controls Need Rethink: Study</a></p><p>A new study concludes that government-imposed drug price controls in India have mainly benefited the country&rsquo;s well-off citizens and do not increase access to medicines for the vast poor population, recommending that measures to improve the situation could include boosting healthcare financing, extending universal health coverage and promoting bulk drug procurement.</p><p><p><a href="https://www.pharmamedtechbi.com/publications/pharmasia-news/2015/7/15/korean-pharmas-urged-to-focus-on-emerging-market-exports" target="_new">Korean Pharmas Urged To Focus On Emerging Market Exports</a></p><p>Despite the South Korean pharma industry's strong efforts to boost exports amid a challenging domestic environment, a domestic research report says the industry still lacks competitiveness in the global market and advises pharma firms to focus more on exports to emerging nations which have high growth potential.</p><p><p><a href="https://www.pharmamedtechbi.com/publications/pharmasia-news/2015/7/15/cautious-industry-welcome-for-new-australian-rampd-fund" target="_new">Cautious Industry Welcome For New Australian R&D Fund</a></p><p>A proposal to establish a new fund to support medical research in Australia has received strong backing from the country's main pharma association, on the condition there is close collaboration with the innovative industry and coordination with other similar initiatives.</p><p><p><a href="https://www.pharmamedtechbi.com/publications/pharmasia-news/2015/7/17/asiapacific-trade-talks-prompt-concerns-optimism" target="_new">Asia-Pacific Trade Talks Prompt Concerns, Optimism</a></p><p>The Public Health Association of Australia has expressed concerns over leaked TRIPS-plus intellectual property proposals from the planned Asian Regional Comprehensive Economic Partnership agreement, while Medicines Australia says the planned Trans Pacific Partnership has the potential to establish high regional standards for IP protection.</p><p><p><a href="https://www.pharmamedtechbi.com/publications/pharmasia-news/2015/7/16/hepalink-shifts-to-drug-development-with-resverlogix-deal" target="_new">Hepalink Shifts To Drug Development With Resverlogix Deal</a></p><p>China's Shenzhen Hepalink Pharmaceutical, a publicly traded company that claims to be one of the largest makers of heparin in the world, has ambitions to build up its research and development activities for innovative drugs and is making substantial investments in overseas companies to achieve them.</p><p><p><a href="http://C:\Users\haydocki\AppData\Local\Microsoft\Windows\Temporary Internet Files\Content.IE5\48J8Q7EI\www.pharmasianews.com" target="_new">www.pharmasianews.com</a></p><p>
----field----
field: {5BA0578F-65B7-4C22-8233-1603D698D8A4}
name: Summary
key: summary
content-length: 244

<p>A new regular roundup of commercial stories appearing in <i>Scrip</i>'s sister publication <i>PharmAsia News</i>, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. </p>
----field----
field: {8F4EE718-6FA0-42A5-85C4-6C8FE8B1FCD4}
name: Navigation Title
key: navigation title
content-length: 32

PharmAsia News business bulletin
----field----
field: {7C4FC796-1311-4DAA-81AC-85EAA2C1C108}
name: Actual Publish Date
key: actual publish date
content-length: 15

20150714T212416
----field----
field: {BDF7C8E1-869E-49FF-B9F5-854B3081A45D}
name: Created Date
key: created date
content-length: 15

20150714T212416
----field----
field: {C926A72A-39DA-446D-B78C-2A650F820A73}
name: Modified Date
key: modified date
content-length: 15

20150714T212416
----field----
field: {1616FE67-7278-4169-948E-C29B00EC8781}
name: Article Number
key: article number
content-length: 8

SC029270
----field----
field: {2C985172-2B37-4CFE-AEDE-2A42EC833941}
name: Content Type
key: content type
content-length: 38

{832554E5-EC9E-4747-8623-6770D36CAF32}
----field----
field: {31603F25-6D9C-4954-BCDE-342E1E184A30}
name: Meta Title Override
key: meta title override
content-length: 32

PharmAsia News business bulletin
----field----
field: {5AD65E47-7554-4CE5-87B0-7FB65051C05A}
name: Authors
key: authors
content-length: 38

{DB39CCA6-EB88-422C-8247-AB4AD01491E2}
----field----
field: {AE1BD751-D4E7-49CB-96C4-62E995A06B51}
name: Article Category
key: article category
content-length: 13

Headline News
----field----
field: {0F6C8F42-01DC-4E05-B63E-AA25D8AA0E09}
name: Legacy Publication
key: legacy publication
content-length: 38

{0F9CCE10-91C1-4F31-832A-266F482A5DAF}
----field----
field: {5795FF15-0942-41FF-8A77-3B73185F5E1B}
name: Escenic ID
key: escenic id
content-length: 6

359425
----field----
field: {25BED78C-4957-4165-998A-CA1B52F67497}
name: __Created
key: __created
content-length: 16

20160209T042424Z
----field----
field: {5DD74568-4D4B-44C1-B513-0AF5F4CDA34F}
name: __Created by
key: __created by
content-length: 18

sitecore\Anonymous
----field----
field: {8CDC337E-A112-42FB-BBB4-4143751E123F}
name: __Revision
key: __revision
content-length: 36

2774507c-0963-4463-ba09-701a93052fa7
----field----
field: {D9CF14B1-FA16-4BA6-9288-E8A174D4D522}
name: __Updated
key: __updated
content-length: 16

20160209T042424Z
----field----
field: {BADD9CF9-53E0-4D0C-BCC0-2D784C282F6A}
name: __Updated by
key: __updated by
content-length: 18

sitecore\Anonymous
